Leave a comment and click here to subscribe for MS article alerts and our newsletter! SC 13G Filing 12/31/2018 D.E. Shaw & Co was reported to have 5.2% ownership of VSTM, coming in at … [Read more...] about D.E. Shaw & Co, L.p. Reveals 5.2% Ownership of VSTM
Introduction Adma Biologics (Nasdaq: ADMA $2.23) is a commercial bio-pharmaceutical company vertically integrated to develop, market, manufacture, and sell specialty plasma-derived products called … [Read more...] about ADMA Tanks After Receiving A CRL For BIVIGAM’s PAS Submission -Should You Buy?
Leave a comment and click here to subscribe for MS article alerts and our newsletter! Adamis Pharmaceutical (NASDAQ: ADMP), a speciality pharmaceutical company, upheld its commitment to file a new … [Read more...] about ADMP Follows Through on Filing A New Drug Application For Tadalafil Sublingual Tablets
Overview The government shutdown. It was a topic of discussion over the holidays which inevitably lead your family down the political "debate" rabbit hole we all vehemently try to navigate away from. … [Read more...] about Implications of A Government Shutdown For Your Portfolio
Leave a comment and click here to sub for MS article alerts and our newsletter! Investing has become crucial to our economy and the dictation of foreign markets. Back in the robber baron days, when … [Read more...] about The Significance of Investing
Note to followers: We apologize for not having the scheduled article on Bristol-Myers Squibb's penetration into the Multiple Myeloma Market ready for publication today. Sultan became ill and couldn't … [Read more...] about An Overview of STXS 3rd Quarter Financial Results And Insider Selling